Trials / Terminated
TerminatedNCT00779844
Anesthesic Propofol and Remifentanil Requirements in Obese Patients
Intravenous Anesthesia in Obese Patients: Propofol and Remifentanil Requirements
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Hopital Foch · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pharmacokinetic models for anesthetic agents are questionable. The objective of the study is to compare the propofol and remifentanil doses required to maintain the bispectral index in the range 40-60 in two groups of patients: obese patients and lean patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | bariatric coelioscopic surgical procedure | total intra-venous anesthesia (propofol and remifentanil) being delivered using a close-loop system with the Bispectral Index as the single input for the controller |
| PROCEDURE | supra-umbilical coelioscopic surgical procedure | total intra-venous anesthesia (propofol and remifentanil) being delivered using a closed-loop system with the Bispectral Index as the single input for the controller |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2008-10-24
- Last updated
- 2016-09-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00779844. Inclusion in this directory is not an endorsement.